Loading insider details...
Beta
Latest Form 4 (Apr 20, 2026): Conversion of 16,875,000 KLRA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 20, 2026 | Kailera Therapeutics, Inc. (KLRA) | Conversion | 16,875,000 | n/a |
| Jun 28, 2024 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 16,000 | $88.3K |
| Jun 7, 2024 | Cerevel Therapeutics Holdings, Inc. (CERE) | Grant/Award | 10,461 | n/a |
| Jan 12, 2024 | Solid Biosciences Inc. (SLDB) | Grant/Award | 904,160 | $5.00M |
| Jun 23, 2023 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 16,000 | n/a |
| Jun 8, 2023 | Solid Biosciences Inc. (SLDB) | Grant/Award | 9,650 | n/a |
| Dec 15, 2022 | Solid Biosciences Inc. (SLDB) | Grant/Award | 9,650 | n/a |
| Dec 5, 2022 | Solid Biosciences Inc. (SLDB) | Grant/Award | 2,666 | n/a |
| Jun 23, 2022 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 16,000 | n/a |
| Jul 21, 2021 | RAPID MICRO BIOSYSTEMS, INC. (RPID) | Conversion | 6,999,998 | n/a |